Replies to post #329955 on Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

Questions I have based on the pre-ind and written responses received

IPIX: In the application, the Company has requested regulatory guidance on its planned Phase 2, randomized, double-blind, placebo-controlled, multi-center study to evaluate the efficacy and safety of Brilacidin in hospitalized patients with COVID-19. Target enrollment is 120 patients, with a planned interim analysis.

1) what was the FDA recommendation
2) is IPIX in agreement with FDA's recommendation

These are 2 very strong pieces of information left out of IPIX's PR that would have given investors the insight as to when human trials will begin

[TheDane]

They don’t sound a lot different but the first one uses more words to same the same thing. I’m sorry you don’t like the CEO or IPIX. Hmm. What can be done about it?